Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 12/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15991616 | 0.92 | LCK (0.39) | LCKCA1CA2PI4KB | |
| SCHEMBL9915439 | 0.92 | LCK (0.39) | LCKCA1CA2PI4KB | |
| SCHEMBL13437680 | 0.86 | LCK (0.39) | LCKCA1CA2PI4KB | |
| SCHEMBL13437782 | 0.84 | LCK (0.39) | LCKCA1CA2PI4KB | |
| SCHEMBL7562740 | 0.84 | LCK (0.42) | LCKCA1CA2 | |
| SCHEMBL5674187 | 0.84 | LCK (0.42) | LCKCA1CA2 | |
| SCHEMBL24635960 | 0.83 | LCK (0.39) | LCKCA1CA2PI4KB | |
| SCHEMBL16002497 | 0.83 | CA1 (0.40) | LCKCA1CA2PI4KB | |
| SCHEMBL24635957 | 0.82 | LCK (0.37) | LCKCA1CA2PI4KB | |
| SCHEMBL5672489 | 0.81 | LCK (0.37) | LCKCA1CA2PI4KB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7696354-B2 | Cephem compounds having broad antibacterial spectrum | SHIONOGI & CO., LTD. (JP) | 2010-04-13 | — | — | US | disclosed |
| US-20090131655-A1 | Cephem Compounds Having Broad Antibacterial Spectrum | SHIONOGI & CO., LTD. | 2009-05-21 | — | — | US | disclosed |
| US-7384928-B2 | Broad spectrum cephem compounds | SHIONOGI & CO., LTD. (JP) | 2008-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131655-A1 | Cephem Compounds Having Broad Antibacterial Spectrum | ZYX, NAT10, NAA50 | LCK 2536/4885CA1 4258/4885CA2 1243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.